Predictors of clinical response to systemic steroids in active ulcerative colitis

Digestive Diseases and Sciences

Volumn 51, Issue 8, 2006, Pages 1434-1438

  Bernal, Isabel ^a   Mañosa, Míriam ^a   Domènech, Eugeni ^a   Garcia Planella, Esther ^a   Navarro, Mercè ^a   Lorenzo Zúñiga, Vicente ^a   Cabré, Eduard ^a   Gassull, Miquel Àngel ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Inflammatory bowel disease; Refractoriness; Steroids; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MESALAZINE; METHYLPREDNISOLONE; PREDNISOLONE; STEROID;

ADULT; CLINICAL ARTICLE; COLON RESECTION; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; HOSPITAL DISCHARGE; HUMAN; INTESTINE MOTILITY; MALE; MALNUTRITION; MEDICAL RECORD REVIEW; MELENA; PREDICTION; PRIORITY JOURNAL; RADIOGRAPHY; REGISTER; REVIEW; STEROID THERAPY; SYSTEMIC THERAPY; TREATMENT FAILURE; TREATMENT RESPONSE; ULCERATIVE COLITIS;

ADULT; COLITIS, ULCERATIVE; COLONOSCOPY; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; MALE; PREDNISONE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33748129611     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9103-7     Document Type: Review

References (20)

1. Faubion WA Jr, Loftus EW Jr, Harmsen WS, Zinsmeister AR, Sandborn WJ (2001) The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 121:255-260
2. Järnerot G, Rolny P, Sandberg-Gertzen H (1985) Intensive intravenous treatment of ulcerative colitis. Gastroenterology 89:1005-1013
3. Meyers S, Level PK, Feuer EJ, Johnson JW, Janowitz HD (1987) Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results a prospective randomized, double-blind trial. J Clin Gastroenterol 9:50-54
4. Domènech E, Garcia-Planella E, Bernal I, Rosinach M, Cabré E, Fluvìa L, Boix J, Gassull MA (2002) Azathioprine without oral cyclosporine in the long-term maintenance of remission induced by intravenous cyclosporine in steroid-refractory severe ulcerative colitis. Aliment Ther Pharmacol 16:2061-2065
5. Järnerot G, Hertervig E, Friis-Liby I, Blomquist L, Karlen P, Grännö Ch, et al (2005) Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 128:1805-1811
6. Lennard-Jones JE (1989) Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 170:2-6
7. Truelove SC, Witts LJ (1955) Cortisone in ulcerative colitis. Final report on the therapeutic trial. Br Med J 2:1041-1048
8. Travis SPL, Farrant JM, Ricketts C, Nolan DJ, Mortensen NM, Kettlewell MGW, Jewell DP (1996) Predicting outcome in severe ulcerative colitis. Gut 38:905-910
9. Benazzato L, D'Incà R, Grigoletto F, Perissinotto E, Medici V, Angriman I, Sturniolo GC (2004) Prognosis of severe attacks in ulcerative colitis: effect of intensive medical treatment. Dig Liver Dis 36:461-466
10. Ho GT, Mowat C, Goddard CJR, Fennell JM, Shah NB, Prescott RJ, Satsangi J (2004) Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery. Aliment Pharmacol Ther 19:1079-1087
11. Lindgren SC, Flood ML, Kilander AF (1998) Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis. Eur J Gastroenterol Hepatol 10:831-835
12. Oshitani N, Kitano A, Fukushima R, Okabe H, Kashima K, Nakamura S, Obata A, Matsumoto T, Okawa K, Kobayashi K (1990) Predictive factors for the response of ulcerative colitis patients during the acute phase treatment. Digestion 46:107-113
13. Chakravarty BJ (1993) Predictor and the rate of medical treatment failure in ulcerative colitis. Am J Gastroenterol 88:852-855
14. Carbonnel F, Gargouri D, Lémman M, Beaugerie L, Cattan S, Cosnes J, Gendre JP (2000) Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis. Aliment Pharmacol Ther 14:273-279
15. Chew CN, Nolan DJ, Jewell DP (1991) Small bowel gas in severe ulcerative colitis. Gut 32:1535-1537.
16. Sandborn WJ, Landers CJ, Tremaine WJ, Targan SR (1996) Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: results of a pilot study. Mayo Clin Proc 71:431-436
17. Vega R, Bertrán X, Menacho M, Domènech E, Moreno de Vega V, Hombrados M, et al (1999) Cytomegalovirus infection in patients with inflammatory bowel disease. Am J Gastroenterol 94:1053-1056
18. Cottone M, Pietrosi G, Martorana G, Casà S, Pecoraro G, Oliva L, et al (2001) Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol 96:773-775
19. Vega R, Domènech E, Hernández A, Ojanguren I, Garcia-Planella E, Bernal I, et al (2004) Prospective study on the prevalence and clinical relevance of cytomegalovirus (CMV) infection in ulcerative colitis (UC). Gastroenterology 126 Suppl 2:A469
20. Forcione DG, Rosen MJ, Kisiel JB, Sands BE (2004) Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease. Gut 53:1117-1122